Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUAM study of fluorescence ureteroscopy-assisted transurethral surgery with oral 5-aminolevulinic acid for upper urinary tract cancer
jRCTs051210042Completed
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of 5-aminolevulinic acid in upper tract urothelial carcinoma (UTUC), renal pelvis cancer and ureteral cancer. Primary endpoint: Progression-free survival. Started Jun 2021; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
upper tract urothelial carcinoma (UTUC)renal pelvis cancerureteral cancer
Beyond the preview
Go deeper on jRCTs051210042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210042.